SCHEMBL662970

SCHEMBL662970

CC(=O)N(C)Cc1cccc(CNC2CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
PRMT5 O14744 1/20 0.44
WDR77 Q9BQA1 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
POLB P06746 2/20 0.43
KDM1A O60341 1/20 0.43
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
OPRM1 P35372 2/20 0.42
OPRL1 P41146 2/20 0.42
PTGES O14684 1/20 0.41
ACHE P22303 1/20 0.41
BACE1 P56817 1/20 0.41
PARP1 P09874 1/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
HSD11B1 P28845 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12138418 0.81 ALDH1A1 (0.42) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL660562 0.80 POLB (0.44) ALDH1A1RAB9AMEN1KMT2APOLB
SCHEMBL10186626 0.78 ALDH1A1 (0.49) ALDH1A1NPC1RAB9APRMT5WDR77
SCHEMBL6911153 0.78 ALDH1A1 (0.51) ALDH1A1NPC1KMT2APOLBKDM1A
SCHEMBL3351084 0.75 ALDH1A1 (0.55) ALDH1A1RAB9AMEN1KMT2APOLB
SCHEMBL425164 0.74 NPC1 (0.68) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL13114705 0.73 HSP90AA1 (0.56) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL19049387 0.73 HSD17B2 (0.61)
SCHEMBL12010812 0.73 ACHE (0.52) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL30444177 0.73 KDM1A (0.54) KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046293-A1 RENIN INHIBITORS MERCK FROSST CANADA LTD. (CA) 2012-02-23 US disclosed
US-20120046293-A1 RENIN INHIBITORS MERCK FROSST CANADA LTD. (CA) 2012-02-23 US disclosed
US-8063105-B2 Renin inhibitors MERCK CANADA INC. (CA) 2011-11-22 US disclosed
US-8063105-B2 Renin inhibitors MERCK CANADA INC. (CA) 2011-11-22 US disclosed
US-8063105-B2 Renin inhibitors MERCK CANADA INC. (CA) 2011-11-22 US disclosed
US-20090281103-A1 Renin Inhibitors MERCK CANADA INC. (CA) 2009-11-12 US disclosed
US-20090281103-A1 Renin Inhibitors MERCK CANADA INC. (CA) 2009-11-12 US disclosed
US-20090281103-A1 Renin Inhibitors MERCK CANADA INC. (CA) 2009-11-12 US disclosed
EP-1910272-A1 RENIN INHIBITORS Merck Frosst Canada Ltd. (CA) 2008-04-16 EP disclosed
WO-2007009250-A1 RENIN INHIBITORS MERCK FROSST CANADA LTD. (CA) 2007-01-25 WO disclosed
WO-2007009250-A1 RENIN INHIBITORS MERCK FROSST CANADA LTD. (CA) 2007-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046293-A1 RENIN INHIBITORS REN, ACE, AGTR1 ALDH1A1 2104/4885NPC1 2069/4885RAB9A 205/4885
US-20090281103-A1 Renin Inhibitors REN, ACE, AGT ALDH1A1 2078/4885NPC1 1488/4885RAB9A 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.